Johnson & JohnsonJNJ stock jumped Wednesday after the Dow Jones health behemoth raised its 2025 guidance in the wake of a bullish second-quarter report.For the year, J&J now expects adjusted earnings …
Dow’s J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific
view original post